Poster Session 1-25 Conditioning regimens/Post-transplant complications

Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)

Chair: Souichi Shiratori (Department of Hematology, Hokkaido University Hospital)

+Add all to schedule

[PS1-25-1] Elderly patients are at high risk of TRM after ASCT with MCEC condition regimen

Keiichi Akizuki, Tomonori Hidaka, Yuki Tahira, Ayako Kamiunten, Masaaki Sekine, Takuro Kameda, Kotaro Shide, Yoko Kubuki, Kazuya Shimoda (Gastroenterology and Hematology, Dept.Int.Med., Miyazaki Univ, Japan)

[PS1-25-2] National survey of total body irradiation prior to hematopoietic stem cell transplantation in Japan

Toshinori Soejima¹, Naoya Ishibashi², Hiroki Kawaguchi³, Takeshi Akiba⁴, Masatoshi Hasegawa⁵, Emiko Shimoda⁵, Kouichi Isobe⁶, Hitoshi Itou⁷, Michiko Imai⁸, Yasuo Ejima⁹, Masaharu Hsta¹⁰, Keisuke Sasai¹¹, Senzou Taguchi¹², Masahiko Oguchi¹², Tetsuo Akimoto¹³ (1.Department of Radiation Oncology, Kobe Proton Center, 2.Department of Radiology, Nihon University School of Medicine, 3.Department of Radiation Oncology, Kobe Minimally Invasive Cancer Center, 4.Department of Radiation Oncology, Tokai University, 5.Department of Radiation Oncology, Nara Medical University, 6.Department of Radiology, Toho University Sakura Medical Center, 7.Department of Radiation Oncology, Kyoto Katsura Hospital, 8.Department of Radiology, Iwata City General Hospital, 9.Department of Radiology, Dokkyo Medical University, 10.Yokohama City University Graduate School of Medicine, 11.Department of Radiation Oncology, Faculty of Medicine, Juntendo University, 12.The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 13.Division of Radiation Oncology, National Cancer Center Hospital East)

[PS1-25-3] Allo-SCT using targeted busulfan-based conditioning regimens for hemodialysis patients

Daisuke Ishihara¹, Taro Tochigi¹, Akihiko Numata¹, Kana Matsumoto², Toshihiro Miyamoto³, Koichi Akashi³ (1.Department of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan, 2.Department of Clinical Pharmaceutics, Doshisha Women's College, Kyoto, Japan, 3.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan)

[PS1-25-4] A retrospective analysis of once-daily administration of intravenous busulfan in allo-HSCT

Naoki Kurita, Tatsuhiro Sakamoto, Takayasu Kato, Manabu Kusakabe, Hidekazu Nishikii, Yasuhisa Yokoyama, Mamiko Sakata-Yanagimoto, Naoshi Obara, Yuichi Hasegawa, Shigeru Chiba (Department of Hematology, University of Tsukuba, Tsukuba, Japan)

[PS1-25-5] Clinical significance of liver injury in the early phase after allogeneic HSCT

Ikuko Omori, Hiroki Yamaguchi, Daishi Onai, Atsushi Marumo, Satoshi Yamanaka, Masahiro Sakaguchi, Yusuke Fujiwara, Shunsuke Yui, Keiko Fukunaga, Takeshi Ryotokuji, Tsuneaki Hirakawa, Masahiro Okabe, Satoshi Wakita, Hayato Tamai, Muneo Okamoto, Kazutaka Nakayama, Koiti Inokuchi (Hematol., Nippon Medical School., Tokyo, Japan)

[PS1-25-6] Effects of rt-thrombomodurin for long-term prognosis after allogeneic stem cell transplantation

Shosaku Nomura, Shinya Fujita, Atsushi Satake, Tomoki Ito, Kazuyoshi Ishii (First Department of Internal Medicine, Kansai Medical University, Hirakata, Japan)

[PS1-25-7] T-cell posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation

Masatomo Kuno¹, Ayumu Ito¹, Akiko Maeshima², Junko Nomoto³, Suguru Fukuhara³, Kazuki Sakatoku¹, Kyosuke Yamaguchi¹, Akihisa Kawajiri¹, Tomonari Takemura¹, Shinichi Makita³, Takashi Tanaka¹, Yoshihiro Inamoto¹, Saiko Kurosawa¹, Sung-Won Kim¹, Koji Izutsu³, Takahiro Fukuda¹ (1.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 2.Pathology, National Cancer Center Hospital, Tokyo, Japan, 3.Hematology, National Cancer Center Hospital, Tokyo, Japan)